AGM/EGMMay 21, 2026, 06:07 AM
Cellectis to Hold AGM June 25; Reports 61.8M Loss for 2025
AI Summary
Cellectis S.A. announced its Combined General Meeting of Shareholders to be held on June 25, 2026, to approve the 2025 financial statements, which reported an annual loss of 61,849,605 and a consolidated loss of $67,592,758. Shareholders will also vote on renewing four board members, authorizing a share buyback program up to 10 million, and approving multiple delegations of authority for future capital increases, including those with cancellation of preferential subscription rights for various investor categories. Additionally, the meeting will address an amendment to the Chairman's age limit and authorizations for stock options and free share allocations.
Key Highlights
- Combined General Meeting scheduled for June 25, 2026, in Paris.
- Approved 2025 annual financial statements show a loss of 61,849,605.
- Approved 2025 consolidated financial statements show a loss of $67,592,758.
- Losses for 2025 ( 61,849,605) allocated to retained earnings, then charged to share premium.
- Four Board of Directors members (Garnier, Arthaud, Boehm, Chartier) proposed for renewal for 3-year terms.
- Authorization for share buyback program up to 10,000,000, max 10 per share, for 18 months.
- Authorization to reduce share capital by canceling up to 10% of shares per 24 months.
- Delegations for capital increases with/without preferential rights, targeting various investors.
Price Impact
More from CLLS